insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...
Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Laboratory Automation Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Laboratory Automation Market ...
The progress in laboratory automation could be one of the most consistent changes in research in the life sciences and biomedicine over the past 30 years. The evolution of this field borders on the ...
The Global Lab Automation Market is estimated to be valued at USD 12.465 Billion by 2035 at an exponential growth of 7.15% in the next seven years. The increasing amount of laboratory tests performed ...
How has technology changed the way we conduct research? Lab automation takes many different forms with the purpose of streamlining several aspects of experiments, data collection and data analysis.
In this interview, we speak to Mostafa ElSayed, CEO of Automata, about their new, open, integrated lab automation platform Automata LINQ and how it unlocks labs' people, space and potential. Please ...
The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results